Target intelligence / Profile preview

No discrete small-molecule-like molecular target

Molecular classification
Other
01

Overview

"No discrete small-molecule-like molecular target" is a classification used in pharmacological databases like ChEMBL to describe drugs that do not interact with a specific protein, enzyme, or receptor (ChEMBL, 2024). Instead, these agents exert their therapeutic effects through broad physicochemical processes. For example, antacids like aluminum hydroxide neutralize gastric acid through direct chemical reaction, while osmotic laxatives such as polyethylene glycol and mannitol create an osmotic gradient to retain water in the intestinal tract (StatPearls, "Osmotic Diuretics"). Other examples include activated charcoal, which acts as an adsorbent to bind toxins, and surfactants like simethicone that reduce the surface tension of gas bubbles (NIH, PubChem). Because these substances lack a specific molecular binding site, they are typically administered in larger doses than targeted small molecules and do not follow traditional structure-activity relationship (SAR) models (Goodman & Gilman's The Pharmacological Basis of Therapeutics). While generally considered safe due to their lack of systemic receptor interaction, they can cause side effects such as electrolyte disturbances or interference with the absorption of concomitantly administered medications.

Other names
Non-specific targetPhysicochemical mechanismNon-proteinaceous targetNon-molecular target
02

Mechanism of action

Physicochemical interaction (e.g., osmosis, neutralization, adsorption, or chelation) rather than binding to a specific biological macromolecule.

03

Biological functions

Other
04

Disease associations

ConstipationDyspepsiaPoisoningEdemaGastroesophageal reflux diseaseOther
05

Safety considerations

Electrolyte imbalanceMalabsorption of nutrientsInterference with drug absorptionSystemic accumulation in renal impairmentGastrointestinal obstruction
06

Interacting drugs

Polyethylene glycol

9 more in the full profile.

Beyond the preview

Go deeper on No discrete small-molecule-like molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No discrete small-molecule-like molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call